vimarsana.com
Home
Live Updates
Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16% : vimarsana.com
Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
Medartis Holding AG / Key word: Annual Results
Medartis increases sales by 21% and improves its underlying EBITDA margin to 16% 12-March-2024 / 06:30 CET/CEST
Release of an ad hoc...
Related Keywords
Switzerland
,
Australia
,
France
,
Spain
,
Tarchamps
,
Rhôalpes
,
Mexico
,
Warsaw
,
L67
,
Poland
,
London
,
City Of
,
United Kingdom
,
Japan
,
Zurich
,
Züsz
,
Germany
,
Austria
,
Colombia
,
Brazil
,
United States
,
Costa Rica
,
Austrian
,
German
,
Swiss
,
Spanish
,
Australian
,
British
,
Zimmer Biomet
,
Inge Maes
,
Martha Shadan
,
Danielb Herren
,
Anthony Durieux
,
Institute In Basel
,
Audit Committee
,
Australian Swiss Chamber
,
Alstom
,
Nextremity Solutions Inc
,
Brazilian Health Regulatory Agency
,
Novartis
,
Field Orthopaedics
,
Keri Medical
,
Ulna Shortening
,
Ulna System
,
Ankle Trauma
,
Field Orthopaedic
,
Medartis Australia
,
Medartis Brazil
,
Great Place
,
Nextremity Solutions
,
Chief Human Resources Officer
,
Anthony Durieux Menage
,
Annual General Meeting
,
Jennifer Dean
,
Independent Non Executive Directors
,
Miach Orthopaedics
,
Rotation Medical
,
Medartis Annual Report
,
Dirk Kirsten
,
General Meeting
,
European Small
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.